Health-care companies rose after a mixed round of earnings.

Health-care companies ticked down after mixed earnings from Big Pharma companies. Investors rotated out of defensive areas into cyclical stocks.

"At the same time, Lilly is building for the future. With our next-generation weight-loss medicine..."